My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2011
Global ID
New Report Calls for Expanded Use of Male Circumcision to Prevent HIV

Medical male circumcision (MC) is a proven, one-time, cost-effective intervention for preventing new HIV infections and should be expanded, according to a new issue brief from the Center for Global Health Policy. Studies of MC in sub-Saharan Africa have already shown that MC can reduce a man’s chance of acquiring HIV through vaginal sex by up to 60 percent.

The Center’s report, “Medical Male Circumcision as HIV Prevention, Follow the Evidence: The case for aggressive scale up,” supports rapidly expanding MC services in countries with high HIV prevalence, low rates of MC, and a predominantly heterosexual epidemic. If fully implemented, MC can save millions of lives and significant resources, says the report, which summarizes the research in this area and outlines strategies for implementation.

“This monograph discusses best practices and highlights some of the recent successes in enhancing access to MC,” said Kenneth H. Mayer, MD, FIDSA, director of the Brown University AIDS Program and co-chair of the Center for Global Health Policy’s Scientific Advisory Committee. “MC is the first biomedical intervention with demonstrated efficacy for HIV prevention, but making it accessible to populations where the epidemic is expanding has proven to be challenging.” 

The issue brief is available to download from the Center’s website. Additional print copies for distribution can be obtained from Center staff at no cost. Read more about the report and MC on the Center’s blog, Science Speaks.

Other recent blog updates include:

  • Calling on President Barack Obama to remember the vital importance of global AIDS funding when finalizing his new budget request, 25 prominent leaders in the field of public health placed a half-page ad in Politico, a Capitol Hill newspaper, in December. The ad asked the president to significantly increase funding for the President’s Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, Tuberculosis and Malaria. See the related blog post for more about the ad).
  • Zeke Emanuel, MD, PhD, has left the White House Office of Management & Budget and returned to his post at the National Institutes of Health (NIH), where he serves as head of the Department of Bioethics at the Clinical Center of the NIH. Kaiser Health News and Politico reported the move. Dr. Emanuel took part in several Science Speaks posts that generated discussion among global health experts, including an Oct. 2010 post on tuberculosis treatment that generated this response.

How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
CLSI Publishes New Breakpoints for Antimicrobial Susceptibility Testing
CDC Issues Guidance on Pre-Exposure Prophylaxis for HIV Prevention
Additional Practice Guidelines Now Available as Pocketcards
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
PQRS and E-Prescribing Resources for ID Physicians
Physicians Excluded from FTC’s Identity Theft Rule
Global ID
New Report Calls for Expanded Use of Male Circumcision to Prevent HIV
Policy and Advocacy
FDA Releases Data on Antibiotic Use on the Farm
IDSA Continues to Weigh In on Consultation Codes
Your Colleagues
Members on the Move
Welcome, New Members!
Education & Resources
IDSA Influenza Conference Available Online, with CME Credit
New Fellowship in Transplant ID Available: 2011 Joint Research Awards
Online CME Available: Antimicrobial Stewardship in a Community Hospital
ABIM Foundation Grants Available for Medical Professionalism Efforts
Top Stories
From the President: The Intersection of Human and Animal Health
IDSA Releases Guideline for Treatment of MRSA Infections
Updated IDSA Guideline on Fever and Neutropenia
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.